EP Patent

EP2914244B1 — Administration of aerosolised iloprost

Assigned to Vectura GmbH · Expires 2024-01-03 · 2y expired

What this patent protects

Patent listed against Remodulin.

Drugs covered by this patent

Remodulin (TREPROSTINIL) · United Therap

Patent Metadata

Patent number: EP2914244B1
Jurisdiction: EP
Classification: —
Expires: 2024-01-03
Drug substance claim: No
Drug product claim: No
Assignee: Vectura GmbH
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.